Aligos Therapeutics, Inc. (ALGS)
5.51
+0.17
(+3.18%)
USD |
NASDAQ |
Oct 12, 09:55
Aligos Therapeutics Market Cap : 34.36M for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 33.30M |
| October 08, 2026 | 33.12M |
| October 07, 2026 | 33.18M |
| October 06, 2026 | 33.55M |
| October 05, 2026 | 33.68M |
| October 02, 2026 | 34.55M |
| October 01, 2026 | 34.30M |
| September 30, 2026 | 35.11M |
| September 29, 2026 | 35.05M |
| September 28, 2026 | 34.55M |
| September 25, 2026 | 34.36M |
| September 24, 2026 | 34.61M |
| September 23, 2026 | 34.68M |
| September 22, 2026 | 35.42M |
| September 21, 2026 | 34.24M |
| September 18, 2026 | 32.68M |
| September 17, 2026 | 32.24M |
| September 16, 2026 | 31.50M |
| September 15, 2026 | 31.12M |
| September 14, 2026 | 31.43M |
| September 11, 2026 | 32.56M |
| September 10, 2026 | 33.24M |
| September 09, 2026 | 34.30M |
| September 08, 2026 | 35.92M |
| September 04, 2026 | 38.73M |
| Date | Value |
|---|---|
| September 03, 2026 | 38.79M |
| September 02, 2026 | 38.73M |
| September 01, 2026 | 37.98M |
| August 31, 2026 | 36.55M |
| August 28, 2026 | 43.10M |
| August 27, 2026 | 44.09M |
| August 26, 2026 | 46.84M |
| August 25, 2026 | 46.59M |
| August 24, 2026 | 43.22M |
| August 21, 2026 | 41.60M |
| August 20, 2026 | 40.16M |
| August 19, 2026 | 42.97M |
| August 18, 2026 | 42.16M |
| August 17, 2026 | 41.01M |
| August 14, 2026 | 42.97M |
| August 13, 2026 | 42.22M |
| August 12, 2026 | 43.66M |
| August 11, 2026 | 45.40M |
| August 10, 2026 | 47.71M |
| August 07, 2026 | 34.86M |
| August 06, 2026 | 34.36M |
| August 05, 2026 | 29.56M |
| August 04, 2026 | 29.62M |
| August 03, 2026 | 28.47M |
| July 31, 2026 | 26.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 321.75M |
| Amgen, Inc. | 224.20B |
| Anika Therapeutics, Inc. | 260.70M |
| BioCryst Pharmaceuticals, Inc. | 2.165B |
| Imunon, Inc. | 4.899M |
Market Cap Related Metrics
| PS Ratio | 1.818 |
| Price to Book Value | 1.078 |
| Price | 5.51 |
| Earnings Yield | -132.8% |